Gastrointestinal Endoscopy
Volume 60, Issue 5 , Pages 695-702 , November 2004

Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial

Received 23 April 2004 ,Revised 30 June 2004 ,Accepted 22 July 2004.

References 

  1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37(Suppl 8):S4–S66
  2. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 2000;29:645–654
  3. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049–2053
  4. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 1999;83:18–29
  5. Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer. 2002;99:751–754
  6. Sagar PM, Gauperaa T, Sue-Ling H, McMahon MJ, Johnston D. An audit of the treatment of cancer of the oesophagus. Gut. 1994;35:941–945
  7. Ell C, May A. Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: a critical review. Endoscopy. 1997;29:392–398
  8. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med. 2001;344:1681–1687
  9. Siersema PD, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy. 2003;35:79–85
  10. Dormann AJ, Eisendrath P, Wigginghaus B, Huchzermeyer H, Deviere J. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy. 2003;35:207–211
  11. Siersema PD, Hop WC, van Blankenstein M, van Tilburg AJ, Bac DJ, Homs MY, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001;54:145–153
  12. Köcher M, Dlouhy M, Neoral C, Buriankova E, Gryga A, Duda M, et al. Esophageal stent with antireflux valve for tumors involving the cardia: work in progress. J Vasc Interv Radiol. 1998;9:1007–1010
  13. Davies RP, Kew J, Byrne PD. Treatment of post-stent gastroesophageal reflux by anti-reflux Z-stent. Cardiovasc Intervent Radiol. 2000;23:487–489
  14. Do YS, Choo SW, Suh SW, Kang WK, Rhee PL, Kim K, et al. Malignant esophagogastric junction obstruction: palliative treatment with an antireflux valve stent. J Vasc Interv Radiol. 2001;12:647–651
  15. Dua KS, Kozarek R, Kim J, Evans J, Medda BK, Lang I, et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc. 2001;53:603–613
  16. Laasch HU, Marriott A, Wilbraham L, Tunnah S, England RE, Martin DF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology. 2002;225:359–365
  17. Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer. 1996;32A:1912–1917
  18. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 1982;23:1060–1067
  19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  20. Christie NA, Buenaventura PO, Fernando HC, Nguyen NT, Weigel TL, Ferson PF, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg. 2001;71:1797–1801discussion 1801-2
  21. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003;52:922–926
  22. Johnson DA, Winters C, Spurling TJ, Chobanian SJ, Cattau EL. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol. 1987;9:23–27
  23. Stein HJ, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg. 1993;105:107–111
  24. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut. 1995;37:7–12
  25. Wishingrad M, Kim M, Triadafilopoulos G. Early dysphagia after placement of a self-expanding esophageal stent: severe esophagitis mimicking luminal occlusion. Am J Gastroenterol. 1995;90:1525–1526

PII: S0016-5107(04)02047-4

Gastrointestinal Endoscopy
Volume 60, Issue 5 , Pages 695-702 , November 2004

Article Tools

* Image Usage & Resolution